IFNG and Mendelian susceptibility to mycobacterial diseases: For severe cases of MSMD—mainly presented by patients with AR complete deficiency of the IFN-γ receptor (IFN-γ)—allogenic hematopoietic stem cell transplantation (alloHSCT) remains the only curative treatment option [23,28].